Importantly, the MARCH1 knockdown caused by the intra‐tumour injection of siRNA targeting MARCH1 drastically reduced tumour growth in vivo in xenograft mouse models with human HCC. The gene discussed is MARCHF1; the disease is hepatocellular carcinoma.